MacroGenics, Inc. (MGNX)
1.40
+0.01
(+0.72%)
USD |
NASDAQ |
Dec 10, 16:00
1.395
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Shareholders Equity (Quarterly): 67.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Gilead Sciences, Inc. | 21.54B |
| Merck & Co., Inc. | 51.85B |
| Pfizer Inc. | 92.80B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 270.76M |
| Total Liabilities (Quarterly) | 203.76M |
| Debt to Equity Ratio | 1.601 |
| Current Ratio | 5.219 |
| Net Debt Paydown Yield | -13.78% |